PATENT CLAIM ANALYSIS

Application Number: 16012872
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "279000"]

Abstract:
Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.

Claim (Index 15):
The method of  claim 14 , wherein the tetrandrine family member has the \u201cS\u201d isomeric configuration at the C-1\u2032 chiral carbon location.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.17241
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14199235', '14025080', '14206633', '14206739', '08484469']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7488720756998668
- 35 USC 102 Novelty (BERT): 0.4705259236242752
- Combined Prediction Score: 0.7210374604923077
- Mean Citation Score: 111.19000520000002
- Max Citation Score: 134.65607
- Similarity Product: 97.3050342564255

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test